Ftse Mib
36.170,93
0,16%
DAX
21.394,93
-0,11%
S&P 500
6.092,45
-0,43%
NASDAQ
19.938,51
-0,57%
Bitcoin
106.264,86
2,21%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sana Biotechnology Inc (SANA) Sana Biotechnology Inc (SANA) Notizie

Sana Biotechnology Inc

SANA
3,5101
0,0201 (0,58%)
Ultimo aggiornamento: 20:01:57
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/1/202522:31EDGAR2Form 144 - Report of proposed sale of securities
13/1/202515:00EDGAR2Form 8-K - Current report
08/1/202522:05GLOBESana Biotechnology to Present at the 43rd Annual J.P. Morgan..
07/1/202522:05GLOBESana Biotechnology Announces Positive Clinical Results from..
16/12/202422:33EDGAR2Form 144 - Report of proposed sale of securities
02/12/202415:00GLOBESana Biotechnology Announces Fast Track Designation for..
27/11/202400:20EDGAR2Form 144 - Report of proposed sale of securities
25/11/202423:40EDGAR2Form 144 - Report of proposed sale of securities
25/11/202422:05GLOBESana Biotechnology to Present at December 2024 Investor..
08/11/202415:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202415:07EDGAR2Form 8-K - Current report
08/11/202415:00GLOBESana Biotechnology Reports Third Quarter 2024 Financial..
04/11/202422:30GLOBESana Biotechnology Announces Increased Focus on Type 1..
23/10/202414:00PRNUSFlagship Pioneering Announces Appointment of Junaid Bajwa as..
21/10/202423:19EDGAR2Form 144 - Report of proposed sale of securities
08/10/202422:05EDGAR2Form 8-K - Current report
03/10/202414:00PRNUSInvaio Sciences Appoints André Andonian as Chairman of the..
30/9/202422:05GLOBESana Biotechnology to Present at the Goldman Sachs Cell..
12/9/202422:36EDGAR2Form 8-K - Current report
29/8/202422:05GLOBESana Biotechnology to Present at September 2024 Investor..
26/8/202422:05GLOBESana Biotechnology Appoints Accomplished Drug Developer..
08/8/202422:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:12EDGAR2Form 8-K - Current report
08/8/202422:05GLOBESana Biotechnology Reports Second Quarter 2024 Financial..
06/8/202412:30PRNUSFlagship Pioneering Announces Appointment of Raj Panjabi as..
15/7/202422:12EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
07/6/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:05EDGAR2Form 8-K - Current report
21/5/202415:00GLOBESana Biotechnology Highlights Publication in Nature..
08/5/202422:49EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/5/202422:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:13EDGAR2Form 8-K - Current report
08/5/202422:05GLOBESana Biotechnology Reports First Quarter 2024 Financial..
06/5/202422:05GLOBESana Biotechnology to Present at May and June 2024 Investor..
08/3/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:12EDGAR2Form 8-K - Current report
29/2/202422:05GLOBESana Biotechnology Reports Fourth Quarter and Full Year 2023..
28/2/202422:05GLOBESana Biotechnology to Present at the Cowen 44th Annual..
13/2/202422:05GLOBESana Biotechnology Announces Publication of Preclinical..
12/2/202422:05GLOBESana Biotechnology Announces Closing of Upsized Public..
08/2/202423:20EDGAR2Form 8-K - Current report
08/2/202422:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202407:22GLOBESana Biotechnology Announces Pricing of Upsized Public..
08/2/202403:59EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
07/2/202423:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/2/202422:12EDGAR2Form 8-K - Current report
07/2/202422:01GLOBESana Biotechnology Announces Proposed Public Offering of..
Apertura: 3,485 Min: 3,33 Max: 3,65
Chiusura: 3,49

La tua Cronologia

NASDAQ
SANA
Sana Biotechnology
BIT
P1OJE5
BNP Paribas Issuance
BIT
P1RKL1
BNP Paribas Issuance
BIT
UB2Y50
UniCredit Bank
BIT
UC84CV
Unicredit Bank
BIT
F06716
Vontobel Financial Produ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network